A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial.
Front Med (Lausanne)
; 8: 717168, 2021.
Article
en En
| MEDLINE
| ID: mdl-34568375
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Guideline
/
Prognostic_studies
Idioma:
En
Año:
2021
Tipo del documento:
Article